COVID-19 Therapeutics I: Restoration of endothelial barrier function by adrecizumab for the treatment of life-threatening organ failure (RESCUE) - Initiation and overall coordination
- Funded by Federal Ministry of Research, Technology and Space (BMFTR)
- Total publications:0 publications
Grant number: 16LW0002K
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Known Financial Commitments (USD)
$485,197.9Funder
Federal Ministry of Research, Technology and Space (BMFTR)Research Location
GermanyLead Research Institution
AdrenoMed AGResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Supportive care, processes of care and managementSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified